Nurix Therapeutics (NRIX) Q1 2026 Earnings

28JanConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.03
-0.86
-0.69
-0.52

Details

Expected EPS
-0.870984
Actual EPS
-0.82
Surprise EPS
0.05
Surprise Percent
+5.85%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.82 per share for Q1 2026.

0 Comments

Share your thoughts